GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lexicon Pharmaceuticals Inc (STU:LX31) » Definitions » Cyclically Adjusted Book per Share

Lexicon Pharmaceuticals (STU:LX31) Cyclically Adjusted Book per Share : €2.08 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Lexicon Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lexicon Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2024 was €1.079. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.08 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Lexicon Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -14.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -15.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -18.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -18.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Lexicon Pharmaceuticals was -13.20% per year. The lowest was -23.40% per year. And the median was -17.55% per year.

As of today (2024-06-09), Lexicon Pharmaceuticals's current stock price is €4.096. Lexicon Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €2.08. Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 1.97.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lexicon Pharmaceuticals was 4.13. The lowest was 0.40. And the median was 1.69.


Lexicon Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Lexicon Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexicon Pharmaceuticals Cyclically Adjusted Book per Share Chart

Lexicon Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.40 1.62 1.86 3.20 3.29

Lexicon Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.39 2.43 4.89 3.29 2.08

Competitive Comparison of Lexicon Pharmaceuticals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Lexicon Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lexicon Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.079/131.7762*131.7762
=1.079

Current CPI (Mar. 2024) = 131.7762.

Lexicon Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.168 100.560 1.531
201409 0.821 100.428 1.077
201412 2.226 99.070 2.961
201503 2.298 99.621 3.040
201506 1.990 100.684 2.605
201509 1.702 100.392 2.234
201512 2.532 99.792 3.344
201603 2.188 100.470 2.870
201606 1.863 101.688 2.414
201609 1.586 101.861 2.052
201612 1.431 101.863 1.851
201703 1.196 102.862 1.532
201706 0.896 103.349 1.142
201709 0.623 104.136 0.788
201712 0.546 104.011 0.692
201803 0.201 105.290 0.252
201806 -0.041 106.317 -0.051
201809 -0.238 106.507 -0.294
201812 -0.219 105.998 -0.272
201903 -0.380 107.251 -0.467
201906 -0.540 108.070 -0.658
201909 1.407 108.329 1.712
201912 0.992 108.420 1.206
202003 0.463 108.902 0.560
202006 -0.089 108.767 -0.108
202009 0.639 109.815 0.767
202012 0.908 109.897 1.089
202103 0.887 111.754 1.046
202106 0.788 114.631 0.906
202109 0.780 115.734 0.888
202112 0.675 117.630 0.756
202203 0.563 121.301 0.612
202206 0.448 125.017 0.472
202209 0.771 125.227 0.811
202212 0.586 125.222 0.617
202303 0.434 127.348 0.449
202306 0.702 128.729 0.719
202309 0.534 129.860 0.542
202312 0.349 129.419 0.355
202403 1.079 131.776 1.079

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Lexicon Pharmaceuticals  (STU:LX31) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lexicon Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.096/2.08
=1.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lexicon Pharmaceuticals was 4.13. The lowest was 0.40. And the median was 1.69.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lexicon Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Lexicon Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexicon Pharmaceuticals (STU:LX31) Business Description

Traded in Other Exchanges
Address
2445 Technology Forest Boulevard, 11th Floor, The Woodlands, TX, USA, 77381
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Lexicon Pharmaceuticals (STU:LX31) Headlines

No Headlines